Efficacy of ivermectin-based drugs against ectoparasites in broiler chickens

This research aimed to study the efficacy of two different ivermectin-based drugs against ectoparasites of chickens. In total 1200 Highsex brown chickens aged 1-1.5 years were examined to determine the prevalence of ectoparasites among chickens. The diagnosis of ectoparasites in chickens was established using clinical and entomological methods. For studying drug efficacy, 20 chickens were selected and divided into two groups (experimental and control) of 10 birds each according to the principle of analogs. A prepared ivermectin-based drug consisting of active substance ivermectin and the auxiliary substances including jojoba Resplanta, diethylene glycol monoethyl ether, Tween-80, benzyl alcohol, and purified water, was administered to the experimental group at a dose of 0.4 ml/L of drinking water (400 μg ivermectin per 1 kg of body weight) twice with a 24-hour interval. The treatment was repeated after 14 days. The control group was administered another drug based on ivermectin in the same dose and manner as the drug given in the experimental group. The efficacy of the drugs was determined by counting the number of ectoparasites per chicken before and after treatment. The clinical condition of the birds was monitored from day 1 to day 28 of the experiment. To evaluate the physiological state of chickens, blood and biochemical tests were performed on day 28 of the experiment. The results revealed that the prevalence of infection with Menacanthus stramineus, Menopon gallinae, and Dermanyssus gallinae in chickens was 34.5%, 21.5%, and 12%, respectively. The number of parasites/chicken after treatment between the experimental and the control group was significantly different. The efficacy of the drugs against ectoparasites in the experimental and control group was 95.6-99.0% and 85.1-91.1%, respectively. The blood tests showed that hematological and biochemical parameters were within physiological norms for both groups. Also, a pharmacokinetic study was performed on 18 ISA cross, 40-day-old chickens administered orally with the test drug at the same dose. The results revealed that ivermectin reached maximum concentration at 30-60 minutes after administration to the bird. After 1 hour, the concentration of the active substance of the drug in the blood serum of chickens decreased sharply and reached the limit of quantification by 12-24 hours. In conclusion, this drug can be recommended for use in poultry as an effective and safe drug for the treatment of arachnoentomosis in birds.